Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS)

CNY 15.72

(-1.63%)

Market Cap (In CNY)

1.57 Billion

Revenue (In CNY)

672.96 Million

Net Income (In CNY)

-26.15 Million

Avg. Volume

1.53 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
8.81-19.79
PE
-
EPS
-
Beta Value
0.243
ISIN
CNE100002XT3
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Binze Zou
Employee Count
-
Website
https://www.sxkh.com
Ipo Date
2017-04-21
Details
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular and cerebrovascular, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company is based in Xianyang, China.